Methods of treating an overweight or obese subject

US9701651B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9701651-B2
Application numberUS-201514802473-A
CountryUS
Kind codeB2
Filing dateJul 17, 2015
Priority dateDec 4, 2008
Publication dateJul 11, 2017
Grant dateJul 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure herein generally relates to methods of treating an overweight or obese condition, and overweight- or obesity-related conditions. In one embodiment, the disclosure provides a method of treating an overweight or obese condition involving administering to the subject in need thereof, an amount of a pharmaceutical composition including a MetAP-2 inhibitory compound, or a salt, ester, or prodrug thereof, effective to result in weight loss in the subject.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound represented by the formula C-D wherein C is represented by: and D is represented by: wherein: Z, R and Y are not present; X is C 1-6 alkyl; P is NH 2 ; and pharmaceutically acceptable salts thereof. 2. The compound of claim 1 , represented by: wherein: X is C 6 alkyl.

Assignees

Inventors

Classifications

  • in which the oxirane rings are condensed with a carbocyclic ring system having three or more relevant rings · CPC title

  • Anorexiants; Antiobesity agents · CPC title

  • in which the oxirane rings are condensed with a carbocyclic ring system having three or more relevant rings · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • C07D303/22Primary

    with monohydroxy compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9701651B2 cover?
The disclosure herein generally relates to methods of treating an overweight or obese condition, and overweight- or obesity-related conditions. In one embodiment, the disclosure provides a method of treating an overweight or obese condition involving administering to the subject in need thereof, an amount of a pharmaceutical composition including a MetAP-2 inhibitory compound, or a salt, ester,…
Who is the assignee on this patent?
Zafgen Inc
What technology area does this patent fall under?
Primary CPC classification C07D303/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).